Enhancement of Antibody Formation against Herpes Simplex Virus in Mice by the T-Cell Mitogen Bestatin

References

1. Allison A. C., Harington J. S., Birbeck M. 1966; An examination of the cytotoxic effects of silica on macrophages. Journal of Experimental Medicine 124:141–154
   [Google Scholar]
2. Andonov P., Dundarov S., Bakalov B., Tomov S., Zenov N., Todorova R. 1978; The effect of killed antiherpes vaccine. In Proceedings, International Congress on Infectious and Parasitic Diseases (Varna, Bulgaria) p 538
   [Google Scholar]
3. Bruley-Rosset M., Florentin I., Kiger N., Schulz J., Mathe G. 1979; Restoration of impaired immune functions of aged animals by chronic bestatin treatment. Immunology 38:75–83
   [Google Scholar]
4. Burns W. H., Billups L. C., Notkins A. L. 1975; Thymus dependence of viral antigens. Nature, London 256:654–656
   [Google Scholar]
5. Friedman R. M., Vogel S. N. 1983; Interferons with special emphasis on the immune system. Advances in Immunology 34:97–140
   [Google Scholar]
6. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J., Kuehl R. A. Jr, Davies P. 1977; Macrophages synthesise and release prostaglandins in response to inflammatory stimuli. Nature, London 269:149–151
   [Google Scholar]
7. Ishikawa T., Hirokawa V. I., Isurugi K. 1978; Effect of a new immunomodulator, bestatin, in the treatment of urogenital malignancies. Abstracts, XII International Congress on Cancer (Buenos Aires)
   [Google Scholar]
8. Ishizuka M., Masuda T., Kanbayashi N., Fukasawa S., Takeuchi T., Aoyagi T., Umezawa H. 1980a; Effect of bestatin on mouse immune system and experimental murine tumors. Journal of Antibiotics 33:642–652
   [Google Scholar]
9. Ishizuka M., Sato J., Sugiyama Y., Takeuchi T., Umezawa H. 1980b; Mitogenic effect of bestatin on lymphocytes. Journal of Antibiotics 33:653–662
   [Google Scholar]
10. Ishizuka M., Aoyagi T., Takeuchi T., Umezawa H. 1981; Activity of bestatin: enhancement of immune responses and antitumor effect. In Small Molecular Immunomodifiers of Microbial Origin: Fundamental and Clinical Studies of Bestatin pp 17–38 Edited by Umezawa H. Oxford: Pergamon Press;
    [Google Scholar]
11. Kirchner H. 1978; Suppressor cells of immune reactivity in malignancy. European Journal of Cancer 14:453–459
    [Google Scholar]
12. Knoblich A., Gortz J., Harle-Grupp V., Falke D. 1983; Kinetics and genetics of herpes simplex virus-induced antibody formation in mice. Infection and Immunity 39:15–23
    [Google Scholar]
13. Levy H. B. 1977; Induction of interferon in vivo by polynucleotides. Texas Reports on Biology and Medicine 35:91–98
    [Google Scholar]
14. Muller W. E. G. 1981; Effect of bestatin on DNA and RNA metabolism in T-cells. In Small Molecular Immunomodifiers of Microbial Origin: Fundamental and Clinical Studies oj Bestatin pp 39–58 Edited by Umezawa H. Oxford: Pergamon Press;
    [Google Scholar]
15. Muller W. E. G., Zahn R. K., Arendes J., Munsch N., Umezawa H. 1979; Activation of DNA-metabolism in T-cells by bestatin. Biochemical Pharmacology 28:3131–3137
    [Google Scholar]
16. Muller W. E. G., Schuster D. K., Zahn R. K., Maidhof A., Leyhausen G., Falke D., Koren R., Umezawa H. 1982; Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells. International Journal of Immunopharmacology 4:393–400
    [Google Scholar]
17. Nishizawa R., Saino T., Takita T., Suda H., Aoyagi T., Umezawa H. 1977; Synthesis and structure-activity relationship of bestatin analogues, inhibitors of aminopeptidase B. Journal of Medical Chemistry 2d:510–515
    [Google Scholar]
18. Saito M., Aoyagi T., Umezawa H., Nagai Y. 1977; Bestatin, a new specific inhibitor of aminopeptidases, enhances activation of small lymphocytes by concanavalin A. Biochemical and Biophysical Research Communications 76:526–533
    [Google Scholar]
19. Snyder D. S., Beller D. J., Unanue E. R. 1982; Prostaglandins modulate macrophage la expression. Nature, London 299:163–165
    [Google Scholar]
20. Suda A., Aoyagi T., Takeuchi T., Umezawa H. 1976; Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer. Archives of Biochemistry and Biophysics 111:196–200
    [Google Scholar]
21. Trang L. E. 1980; Prostaglandins and inflammation. Seminars in Arthritis and Rheumatism 9:153–189
    [Google Scholar]
22. Umezawa H. 1981; Small molecular weight immunomodifiers produced by microorganisms: their screening and discoveries and the genetics of microbial secondary metabolites. In Small Molecular Immunomodifiers of Microbial Origin: Fundamental and Clinical Studies of Bestatin pp 1–15 Edited by Umezawa El. Oxford: Pergamon Press;
    [Google Scholar]
23. Umezawa H., Ishizuka M., Aoyagi T., Takeuchi T. 1976a; Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and Leucine aminopeptidase. Journal of Antibiotics 29:857–859
    [Google Scholar]
24. Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T. 1976b; Bestatin, a new aminopeptidase B inhibitor produced by actinomycetes. Journal of Antibiotics 29:97–99
    [Google Scholar]
25. Zisman B., Hirsch M. S., Allison A. C. 1970; Selective effects of antimacrophage serum, silica and antilymphocyte serum on the pathogenesis of herpesvirus infection in young adult mice. Journal of Immunology 104:1155–1159
    [Google Scholar]